Why the study?
Does dolasetron improve patient satisfaction compared to ondansetron for PONV prophylaxis in ambulatory surgery patients?
Does dolasetron improve patient satisfaction compared to ondansetron for PONV prophylaxis in ambulatory surgery patients?
Dolasetron and ondansetron provide similar patient satisfaction for PONV prophylaxis, supporting the use of cost-minimization strategies without compromising care.
Answers are grounded in this paper and cite their sources.
Supports cost-minimization strategies without compromising care; confirms similar satisfaction between agents in ambulatory surgery.
This study identified 100 ambulatory surgery patients receiving general anesthesia who were at increased risk for postoperative nausea and vomiting (PONV) and randomly assigned them to receive single-agent prophylaxis (12.5 mg of dolasetron or 4 mg of ondansetron) 15 to 30 minutes before the end of surgery. Data were collected in the postanesthesia care unit, and patients completed a questionnaire 24 hours after surgery. No statistically significant difference existed between study groups in demographic features, history of PONV, history of motion sickness, or type and duration of surgery and anesthesia. No statistically significant difference existed in satisfaction with the medication used for PONV prophylaxis (dolasetron, 70.9 of 100 mm; ondansetron, 67.9 of 100 mm; p = 0.69). No statistically significant difference existed in satisfaction with the overall surgical experience (dolasetron, 87.9 of 100 mm; ondansetron, 85.3 of 100 mm; p = 0.36). Costminimization strategies should be considered without fear of substandard care or increased patient dissatisfaction.
No takes yet. Share an insight, caveat, or question.
Birmingham et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: